is glp 1 oral effective Patients taking an experimental GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other Oral GLP-1 Analogues (Semaglutide) -

The aim is evenness, which means bringing darker patches back towards your own baseline rather than shifting that baseline, and the dramatic whitening claims attached to glutathione come from injectable use, an entirely different dose and route

Initially Too Strange Endocrinologist John Eng played a central role in turning that insight into a drug lead

The study was supported by the UTSW Clinical and Translational Science Award, the National Institutes of Health (1U54TR00236), the Texas Health Resource Clinical Scholar program, and the UTSW Nutrition & Obesity Research Center (NORC)

This intermediate dose provides a stepping stone for individuals progressing toward higher maintenance doses